Papers
6
Total Citations
100
H-Index
3
About
J.H. Heinzerling is a radiation oncologist whose research centers on stereotactic body radiation therapy (SBRT) for breast cancer, with a particular focus on partial-breast irradiation (PBI). Their most significant contribution is leading a Phase 1 dose-escalation trial that investigated the use of 5-fraction SBRT for early-stage breast cancer after partial mastectomy. This pivotal work, published in 2017 and garnering 66 citations, demonstrated the feasibility and tolerability of escalating radiation doses using a robotic stereotactic system, laying groundwork for more precise, shorter treatment courses. Heinzerling also advanced the technical optimization of SBRT delivery, notably through research on normalized prescription isodose selection. By comparing conventional linear accelerators to robotic platforms, they identified strategies to minimize normal tissue irradiation while maximizing tumor dose—a contribution that has informed treatment planning across institutions. Additionally, Heinzerling has explored the broader role of radiotherapy in metastatic disease, reflecting a commitment to expanding radiation’s therapeutic reach. Their work bridges clinical trial innovation and dosimetric optimization, making them a respected voice in the evolution of breast cancer radiotherapy.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5The Role of Radiotherapy in the Treatment of Metastatic Disease2 citations · 2011
- 6